Explain Where New Eucrisa Fits Into Eczema Treatment

February 2017

The new Eucrisa (you-KRIS-ah, crisaborole) ointment will raise questions about how to manage eczema.

Eucrisa is the first new drug approved for eczema in over a decade. It inhibits phosphodiesterase 4...an enzyme that promotes inflammation.

Think of Eucrisa as a possible second-line med option for mild to moderate eczema...after topical corticosteroids.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Interactions Follow These Rules of Thumb to Manage Drug Interactions
Diabetes Consider Risks and Benefits When Recommending Metformin Add-Ons
Smoking Cessation Expect Less Concern Over Psychiatric Effects With Chantix
Allergic Reactions Help Patients Find an Epinephrine Auto-Injector That Meets Their Needs
NSAIDs Ease Concerns About Using NSAIDs After Most Fractures
COPD Expect Fewer Inhaled Steroids to Be Used for COPD
Muscle Relaxants Recommend Limiting Use of Muscle Relaxants to 7 Days for Acute Low Back Pain
Interactions Watch for Statin Interactions With Pradaxa
Eczema Explain Where New Eucrisa Fits Into Eczema Treatment
Hypotension Consider Med Causes and Suggest Nondrug Measures in Orthostatic Patients
Renal & Urology Explain When Alpha-Blockers May Be Helpful for Kidney Stones
Side Effects Address Taste Disturbances to Prevent Med Adherence Issues
Nasal Sprays Help Clear Up Confusion With Two New OTC Fluticasone Nasal Sprays